SCHEMBL3083453

SCHEMBL3083453

CC(C)OC(C)C.CCCC(O)O

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.38
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.32
CHRM1 P11229 1/20 0.31
AKR1A1 P14550 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
SPHK1 Q9NYA1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL27841210 0.89 CHRM1 (0.39) TSHRLMNACHRM1AKR1A1CHRM3
Isopropyl Alcohol SCHEMBL11812470 0.82 TSHR (0.45) TSHRHSD17B10LMNACHRM1AKR1A1
SCHEMBL3203619 0.82 TSHR (0.45) TSHRHSD17B10LMNACHRM1AKR1A1
SCHEMBL28703 0.82
SCHEMBL11142874 0.82 TSHR (0.42) TSHRLMNACHRM1AKR1A1CHRM3
Methoxymethane SCHEMBL3268353 0.79 TSHR (0.36) TSHRHSD17B10LMNACHRM1AKR1A1
SCHEMBL16782640 0.79 TSHR (0.47) TSHRHSD17B10LMNATDP1
SCHEMBL2458705 0.79 TSHR (0.43) TSHRHSD17B10LMNACHRM1AKR1A1
Methoxymethane SCHEMBL107532 0.79
Hydrochloric Acid SCHEMBL483390 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8734762-B2 Perfluorocarbon nano-emulsion containing quantum dot nanoparticles and method for preparing the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2014-05-27 US claimed
EP-3484841-B1 DECENE OLIGOMERS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2021-08-04 EP disclosed
EP-3083527-B1 METHOD FOR MAKING POLYOLEFINS USING ALUMINUM HALIDE CATALYZED OLIGOMERIZATION OF OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2021-05-19 EP disclosed
US-10927052-B2 Decene oligomers CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2021-02-23 US disclosed
US-20200207682-A1 DECENE OLIGOMERS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2020-07-02 US disclosed
US-10647626-B2 Decene oligomers CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2020-05-12 US disclosed
EP-3484841-A1 DECENE OLIGOMERS Chevron Phillips Chemical Company LP (US) 2019-05-22 EP disclosed
US-20180016204-A1 Decene Oligomers CHEVRON PHILLIPS CHEMICAL COMPANY LP 2018-01-18 US disclosed
WO-2018013249-A1 DECENE OLIGOMERS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-01-18 WO disclosed
US-9708549-B2 Method for making polyalphaolefins using aluminum halide catalyzed oligomerization of olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2017-07-18 US disclosed
EP-3083527-A1 METHOD FOR MAKING POLYOLEFINS USING ALUMINUM HALIDE CATALYZED OLIGOMERIZATION OF OLEFINS Chevron Phillips Chemical Company LP (US) 2016-10-26 EP disclosed
WO-2015095336-A1 METHOD FOR MAKING POLYOLEFINS USING ALUMINUM HALIDE CATALYZED OLIGOMERIZATION OF OLEFINS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2015-06-25 WO disclosed
US-20150166429-A1 Method for Making Polyalphaolefins Using Aluminum Halide Catalyzed Oligomerization of Olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2015-06-18 US disclosed
US-8734762-B2 Perfluorocarbon nano-emulsion containing quantum dot nanoparticles and method for preparing the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2014-05-27 US disclosed
US-20100233094-A1 PERFLUOROCARBON NANO-EMULSION CONTAINING QUANTUM DOT NANOPARTICLES AND METHOD FOR PREPARING THE SAME KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECH (KR) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180016204-A1 Decene Oligomers OXER1, OR10J3, ALOX12 TSHR 4672/4885HSD17B10 27/4885LMNA 2199/4885
US-10927052-B2 Decene oligomers OXER1, OR10J3, ALOX12 TSHR 4672/4885HSD17B10 27/4885LMNA 2199/4885
US-10647626-B2 Decene oligomers OXER1, OR10J3, ALOX12 TSHR 4672/4885HSD17B10 27/4885LMNA 2199/4885
US-20200207682-A1 DECENE OLIGOMERS OXER1, OR10J3, ALOX12 TSHR 4672/4885HSD17B10 27/4885LMNA 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.